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objective. In-hospital transmission of methicillin-susceptible Staphylococcus aureus (MSSA) among neonates remains enigmatic. We
describe the epidemiology of MSSA colonization and infection in a 30-bed neonatal ward.
design. Multimodal outbreak investigation
setting. A public 800-bed tertiary care university hospital in Switzerland
methods. Investigations in 2012–2013, triggered by a MSSA infection cluster, included prospective MSSA infection surveillance, micro-
biologic screening of neonates and environment, onsite observations, and a prospective cohort study. MSSA isolates were characterized by
pulsed-ﬁeld gel electrophoresis (PFGE) and selected isolates were examined for multilocus sequence type (MLST) and virulence factors.
results. Among 726 in 2012, 30 (4.1%) patients suffered fromMSSA infections including 8 (1.1%) with bacteremia. Among 655 admissions
in 2013, 13 (2.0%) suffered from MSSA infections including 2 (0.3%) with bacteremia. Among 177 neonates screened for S. aureus carriage,
overall 77 (44%) tested positive. A predominant PFGE-1-ST30 strain was identiﬁed in 6 of 30 infected neonates (20%) and 30 of 77 colonized
neonates (39%). This persistent clone was pvl-negative, tst-positive and belonged to agr group III. We found no environmental point source.
MSSA carriage was associated with central vascular catheter use but not with a particular midwife, nurse, physician, or isolette. Observed
healthcare worker behavior may have propagated transmission via hands and fomites. Despite multimodal interventions, clonal transmission
and colonization continued and another clone, PFGE-6-ST5, became predominant.
conclusions. Hospital-acquired MSSA clones represent a high proportion of MSSA colonization but not MSSA infections in neonate
inpatients. In contrast to persisting MSSA, transmission infection rates decreased concurrently with interventions. It remains to be established
whether eradication of hospital-acquired MSSA strains would reduce infection rates further.
Infect. Control Hosp. Epidemiol. 2015;00(0) :1–8
Transmission of Staphylococcus aureus in healthcare settings,
including among newborns, is frequent.1–3 Despite a similar
attributable mortality between methicillin-resistant S. aureus
(MRSA) and methicillin-susceptible S. aureus (MSSA),4
literature focuses almost exclusively on MRSA.1,5 S. aureus
persistently colonizes ~20%–40% of healthy individuals6 and
~5%–55% of infants, including neonates.7–10 Several bacterial
and host factors play roles in the process of colonization,6,11,12
and the risk of infection is 3 to 6 times higher in colonized
individuals compared with noncolonized individuals.13–15
There are no generally accepted recommendations to
decolonize neonates for MSSA. Furthermore, no solid data
exist on overall MSSA infection rates in this population.
A monoclonal cluster of 5 MSSA infections among neonates
in our hospital’s 30-bed neonatal ward (NNW) in January
2012 triggered an in-depth investigation of S. aureus epide-
miology during 2012–2013 to elucidate strain clonality,
potential reservoirs, and transmission routes in this popula-
tion. The objective of this report is to add real-world epide-
miological data to the recent debate regarding the infectious
risk engendered by MSSA colonization in neonates and the
consequential need for interventions.
PREVIOUS PRESENTATION: Parts of this study were presented as an oral presentation at the Interscience Conference on Antimicrobial Agents and Chemotherapy,
San Francisco, California, USA, September 17–23, 2012.
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study population
Setting
The NNW at the University Hospital of Zurich, Switzerland,
features 30 beds for neonates including 8 beds for neonatal
intensive care and 5 beds for intermediate care. The average
nurse-to-patient ratio in 2012 was 1:3 during the day and 1:4
during night shifts.
The hospital’s infection surveillance program includes daily
reviews of clinical microbiology and virology results targeted
on epidemiologically important pathogens, and surgical
site infections associated with selected surgical procedures
(eg, cardiac surgery, appendectomy, etc.). Annual institution-
wide prevalence studies are conducted as well.
Case Deﬁnitions
A case was deﬁned as a newborn admitted to the NNW
between January 1, 2011, and December 31, 2013, from whom
S. aureus had been isolated. We distinguished between
S. aureus colonization and infection. The latter was deﬁned as a
positive S. aureus culture and clinical signs of infection, with or
without bacteremia.
methods
Outbreak Investigation
Epidemiological investigation. The outbreak investigation
consisted of 3 distinct periods: (1) a retrospective period
during 2011 with identiﬁcation of cases with S. aureus
infections that occurred based on isolation of S. aureus and
documented symptoms; (2) a prospective 6-week surveillance
screening period from February 20 through April 1, 2012, of all
neonates for nasal S. aureus carriage at the day of delivery, at
the day of ward discharge, and once weekly every Monday;
(3) a follow-up period during 2012–2013 with prospective
surveillance of S. aureus infections detected during regular ward
rounds by 3 investigators (YA, ND, EA) and positive
microbiological samples. Bacteremia of any etiology was
recorded. Colonization was monitored by repeated prevalence
screenings of the nares of all neonates at convenient time points.
Additional source investigation. The following additional
source investigation activity was conducted: environmental
microbiological sampling (isolettes, vital sign monitors,
stethoscopes, telephones, computer mice, ultrasound heads,
and preparations of enteral feeding solutions); extensive onsite
observations including time–motion studies of care activity
and standardized hand hygiene observation according to the
World Health Organization’s “My Five Moments of Hand
Hygiene” method;16,17 assessment of alcohol-based hand rub
consumption; documentation of all cases and controls with
demographic and clinical information.
The Zurich Ethics Review Board formally waived the
necessity for an ethics evaluation.
Risk Factor Analysis
To assess risk factors for the presence of MSSA and for MSSA
carriage, 2 analyses were performed on the prospective 6-week
cohort. Differences in means and medians were compared
using the Student t test and the Wilcoxon rank-sum test,
respectively, and differences in group proportions were eval-
uated using χ2 or Fisher’s exact tests, as appropriate.
Multivariate logistic regression analyses was used to assess
risk factors for MSSA carriage. Risk factors with P< .1 in
univariate analyses were considered for inclusion in multi-
variate models based on clinical judgment. The limited num-
ber of outcomes was factored in when building the models to
prevent overﬁtting. Variables with logically suspected
collinearity were excluded from multivariate models. All
calculations were performed using Stata software, version 11.2
(Stata Corp, College Station, Texas, USA). P< .05 was
considered statistically signiﬁcant.
Microbiology
Sample collection. Samples were obtained from the nares
of neonates and from various surfaces using cotton swabs
premoistened with sterile saline. In addition, ﬁngers of
healthcare workers (HCWs) were swiped directly onto agar
plates. Enteral nutrition (Adapta, Prematil) and additives
(Frauen Milch supplement and maltodextrin) were collected
as liquid samples from ready-to-use milk bottles.
Bacterial identiﬁcation. Nasal swabs, enteral nutrition, and
environmental swabs were plated directly onto Columbia
nalidixic acid blood agar and sheep blood agar plates
(BioMérieux, Marcy l’Etoile, France) and incubated for
24–48 h at 37°C. For HCW ﬁnger sampling, tryptic soy agar
plates with neutralizers (Merck, Kenilworth, NJ) were used.
Isolates were identiﬁed as S. aureus by positive catalase and
StaphAureux tests (Remel Europe, Dartford, Kent, UK).
Oxacillin, cefoxitin, and ampicillin resistance tests were
performed using the Kirby-Bauer disc diffusion method.
Pulsed-ﬁeld gel electrophoresis. The ﬁrst S. aureus isolate
detected in a given neonate and all the S. aureus isolates from
the environment were characterized by pulsed-ﬁeld gel
electrophoresis (PFGE) of total-genome SmaI (New England
Biolabs, Ipswich, MA) digests as previously described.18 The
resulting patterns were analyzed by visual inspection,
photocopying by Gel Doc XR (Bio-Rad, Rheinland,
Switzerland), and by automated analysis using the
GelCompar II computer software (Applied Maths, Kortrijk,
Belgium) for relatedness evaluation.
agr grouping and detection of tst and pvl genes.
Representative S. aureus isolates belonging to PFGE types
that occurred at least 3 times were grown in Luria-Bertani
broth medium (Difco Laboratories, Detroit, MI) at 37°C until
the stationary growth phase. Genomic DNA used as template
for polymerase chain reaction (PCR) was extracted using a
standard phenol-chloroform procedure.19 agr typing was
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performed by multiplex PCR using previously described
primers and conditions.20 S. aureus strains RN6390, RN6607,
Sanger252, and RN8540, corresponding to agr functional
groups I, II, III, and IV, respectively, were obtained from the
Network on Antimicrobial Resistance in S. aureus (NARSA) and
served as controls. Results from agr-PCRs served as positive
controls for the integrity of genomic DNA extracts, which were
also used for the detection of tst and pvl genes using previously
published methods.20,21 pvl encodes for Panton-Valentine
leukocidin, a pore-forming toxin that targets phagocytic
leukocytes, especially polymorph-nuclear leukocytes, which
constitute the ﬁrst line of defense against invading S. aureus.22
tst encodes for toxic shock syndrome toxin, a S. aureus
superantigen responsible for toxic shock syndrome. Strains
N315 and JE2 (also from NARSA) were used as controls for the
speciﬁcity of PCR ampliﬁcations for tst and pvl, respectively.
Multilocus Sequence Typing (MLST)
The allelic proﬁles, referred to as the sequence types of repre-
sentative strains of a distinct PFGE type that included >2 strains,
were deﬁned by the nucleotide sequence of an internal fragment
of 7 housekeeping genes (arcC-aroE-glpF-gmk-pta-tpi-yqiL), as
previously described.23 MLST allele names and STs were derived
using the MLST database (http://www.mlst.net).
results
Retrospective Cases in 2011
Among 697 neonates hospitalized during 2011, 26 cases
(3.7%) of MSSA infection occurred (Figure 1A) including
8 (1.2%) with bacteremia. Strains were generally unavailable
for typing.
Prospective 6-Week Surveillance Screening Period in 2012
During the 6-week surveillance screening period in early 2012,
all 87 admissions were included in this study. Of those, 26
infants were asymptomatic nasal carriers (30%) and 3 had
infections (3.5%), including 1 neonate with conjunctivitis, 1
with bronchopneumonia, and 1 with bacteremia secondary to
a skin infection. A predominant MSSA strain, PFGE-1-ST30,
was found in 11 carriers (42%) but not among infected infants.
Follow-Up Period During 2012–2013
Infections with S. aureus during 2012–2013. In 2012, 726
infants were hospitalized in our NNW; of these, 30 (4.1%)
were infected with MSSA, and 8 (1.1%) suffered from
bacteremia (Figure 1). Of 30 MSSA infections, 6 (20%) were
caused by PFGE-1-ST30, 4 by PFGE-1a-ST30, 2 by PFGE-1b-
ST30, 1 by PFGE-3-ST34, 2 by PFGE-6-ST5. The remaining
15 infections were caused by other PFGE types with distinct
patterns (Figure 2).
In 2013, the incidence of MSSA infections decreased to
2.0% (13 of 655 admissions; P= .03) and the incidence of
bacteremia decreased to 0.3% (2 of 655 admissions; P= .11).
None of the infections were caused by the 2012 MSSA
PFGE-1-ST30 predominant strain. Of the 13 MSSA infections,
4 were caused by PFGE-6-ST5 and 2 were caused by PFGE-4-
ST109, both of which were already present in 2012 (Figures 1
and 2). In addition, 2 infections (including the bacteremia)
were caused by PFGE-2-ST45, which had already caused
bacteremia in 2011 (Figures 1 and 2). The remaining infections
were caused by isolates with distinct PFGE patterns (Supple-
mentary Figure 2).
In 2012, the incidence of bacteremia caused by any micro-
bial pathogen was 4.7% (34 of 726 admissions). Of these
34 cases, 13 bacteremia cases (38%) were caused by coagulase-
negative staphylococci; 8 (24%) by S. aureus; 8 (24%) by
Streptococcus spp.; 3 (9%) by Biﬁdobacterium spp.; 1 (3%) by
Enterococcus spp.; and 1 (3%) by Escherichia coli. No incidents
of Klepsiella pneumonia, Citrobacter spp., or Eikenella spp. were
identiﬁed in 2012. In 2013, the incidence of bacteremia caused
by any microbial pathogen was 3.5% (23 of 655 admissions).
Of these 23 cases, 11 (48%) were caused by coagulase-negative
staphylococci; 2 (9%) by S. aureus; 1 (4%) by Biﬁdobacterium
spp; 1 (4%) by Enterococcus spp., 3 (13%) by Escherichia coli;
1 (4%) by Klepsiella pneumoniae; 1 (4%) by Citrobacter spp.;
and 1 (4%) by Eikenella spp.
Colonization with S. aureus during 2012 and 2013. In 2012,
150 of all 726 neonate admissions (21%) were screened for
S. aureus colonization. Of these 150 neonates, 62 (41%) tested
positive for MSSA carriage; 27 of these 62 (44%) were
identiﬁed as the PFGE-1-ST30 strain. Ten point-prevalence
screening studies during 2012 resulted in a median MSSA
carriage of 52% (range, 24%–75%). Of these, 17%–92% were
identiﬁed as PFGE-1-ST30 strains (Figure 1B). Colonization
with PFGE-1-ST30 was persistently found in prevalence
screenings. PFGE-1-ST30 is pvl-negative, tst-positive, and
belongs to agr group III. The 2 related PFGE types 1a and 1b
differed by 1 and 2 bands, respectively, and also belonged to
the ST30 strain. Another clustered strain also differed from
PFGE-1-ST30 in 1 band and was typed as PFGE-3-ST34
(Figure 2). Supplementary Figure 1 displays the remaining
PFGE strain patterns during 2012.
In 2013, in a single prevalence screening during week 42, we
found 15 MSSA carriers among 27 screened neonates (56%), of
whom 3 (11%) were colonized with PFGE-1-ST30 and 8 (57%)
were colonized with PFGE-6-ST5 (Figure 1B). PFGE-1-ST30
also caused 3 infections in the ﬁrst half of 2013 (Figure 1A).
None of the S. aureus strains was methicillin resistant.
Source Investigation
Repeated time-motion studies revealed non-conforming
HCW behavior that could explain hand transmission of
S. aureus directly or via fomites, eg, touching monitors or
incubator doors of consecutive patients without intermittent
methicillin-susceptible s. aureus in neonates 3
hand cleansing. HCWs frequently used portable phones,
calculators, computers, or incubators in sequence without
hand hygiene. During our observations in the unit, we could
not single out a particular HCW with extremely low hand
ﬁgure 1. Epidemiology of Staphylococcus aureus infection and colonization, 2011–2013.
MSSA, methicillin-suseptible Staphylococcus aureus; 1, strain PFGE-1-ST30; 1a, strain PFGE-1a-ST30; 1b, strain PFGE-1b-ST30; 2, strain
PFGE-2-ST45; 3, strain PFGE-3-ST34; 4, strain PFGE-4-ST109; 6, strain PFGE-6-ST5. (A) Incidence of Staphylococcus aureus infections
among all neonates (B) Prevalence assessments of Staphylococcus aureus colonization and preventive measures
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hygiene compliance or obvious skin disease who appeared to
be a potential super-spreader. Isolettes were cleaned according
to protocol based on probing observations.
Overall, we performed 43 environmental swabs, of which
3 swabs (7%) were positive for MSSA. Of these 3 swabs, 2 were
positive for PFGE-1-ST30: 1 on a bedside monitor and 1 on an
isolette door handle of a colonized neonate with the same
strain. The third MSSA-positive swab was a unique strain
found on a computer mouse in an ofﬁce space. No S. aureus
grew from delivery facilities or milk preparations.
From 3 of 13 conveniently tested HCWs, MSSA was isolated
from ﬁngers before hand cleansing and from the ﬁngers of 1
HCW after hand cleansing. None of these MSSA strains were
PFGE-1-ST30 or any other clustered strain.
Risk Factor Analysis
Of the 87 neonate patients in the prospective 6-week cohort,
29 carried any MSSA and 11 carried the predominant PFGE-1-
ST-30 strain. MSSA acquisition was independently associated
with vascular catheterization (Table 1) but not with any
particular midwife, nurse, or physician. Statistical power was
too limited to detect differences between MSSA acquisition in
general and acquisition of PFGE-1-ST-30.
Control Measures
Control measures were sequentially reinforced as the persistence
of clonally related MSSA strains became clear (Figure 2). All
HCWs were repeatedly informed about the outbreak and its
most likely transmission pathways. Each bed was newly equip-
ped with alcohol-based hand rub dispensers, and portable
100-mL containers were introduced. Training sessions were held
based on the “Five Moments of Hand Hygiene” concept in fall
2012. Overall performance was 66% (162 of 245) before and
73% (148 of 202) after training sessions (adjusted odds ratio,
1.18; 95% conﬁdence interval, 0.77–1.82, multivariate logistic
regression controlling for professional category and indica-
tions).17 Hand rub consumption increased 19% from 189 L per
1,000 patient days in 2012 to 224 L in 2013 (P< .001). Cleaning
and disinfection schedules were intensiﬁed and well applied
according to audits. The NNWwas never closed for admissions,
and no contact isolation or cohorting was introduced. On
September 5, 2012, the entire NNW moved to a newly con-
structed and equipped location in the hospital.
discussion
A cluster of 5 S. aureus infections in neonates triggered an
outbreak investigation including extensive screening of
asymptomatic carriers. We identiﬁed a predominant MSSA
clone PFGE-1-ST30. This clone persisted and accounted for
20% of the MSSA infections and 39% of all nasal swabs
growing MSSA. In 2013, a new clone, PFGE-6-ST5, became
predominant. Other minor clusters occurred and were also
responsible for infections. Intensiﬁed infection control efforts
and moving the unit to a new location did not stop S. aureus
transmission but infection incidence did decrease, in 2013. We
inferred that, once introduced by HCWs or parents, PFGE-1-
ST30 and other clonal MSSA strains were propagated among
neonates through direct and indirect hand transmission,
which is a notoriously efﬁcient pathway in neonatology.24
Although vertical transmission from mothers to neonates
occurs habitually,25 this does not explain the striking clonality.
S. aureus has been shown to survive for up to 8 weeks on inani-
mate surfaces.26–28 We detected PFGE-1-ST30 on a monitor and
an incubator door of a neonate colonized with the same strain,
but these surfaces were unlikely sustained point sources because
they are cleaned repeatedly. Furthermore, and very importantly,
persistence of clones beyond moving to an entirely new facility
makes a persistent environmental point source unlikely.
Colonized HCWs have been responsible for S. aureus out-
breaks in neonates.2,29,30 We found hands of 3 HCWs to be
positive for MSSA, providing proof for at least transient MSSA
hand carriage. Without systematic HCW screening, we cannot
formally exclude the possibility that a colonized HCW acted as a
point source. However, it is unlikely that 1 person colonized so
ﬁgure 2. Selected clustered Staphylococcus aureus genotype patterns.
Staphylococcus aureus multilocus sequence typing (MLST) of the outbreak strain with pulsed-ﬁeld gel electrophoresis (PFGE) identiﬁcation
number 1, its 3 variants (1a, 1b, and 3) with similar PFGE patterns and other clones that occurred at least 3 times between January 2011 to
December 2013 in the neonatal ward. For each clone, 1 representative isolate is shown. ID, strain identiﬁcation; Year*, year in which the
respective clone was detected; PFGE ID, PFGE identiﬁcation; agr, pvl, tst, virulence factors; ST, sequence type.
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many infants. The case control studies did, however, exclude the
existence of a source individual on the obstetric team.
In our 2 case-control studies, we found birth weight,
prolonged length of stay, and use of vascular catheters to be
independent risk factors for MSSA acquisition in general as
well as speciﬁcally for PFGE-1-ST30 acquisition. Graham et al2
described a similar correlation of colonization/infection with
length of hospital stay.
Many effective outbreak control strategies have been
described in the literature including cohorting of neonates and
HCW, strong leadership, staff training in proper hand hygiene,
readily accessible alcohol-based hand sanitizer at the point of
care, decolonization with mupirocin,31,32 and closing the ward
for in-depth cleaning. A recent study documented reduction
of MSSA colonization and infection by unselective use of
mupirocin.33 However, mupirocin use harbors the risk of
table 1. Prospective Cohort of 87 Neonates with Surveillance Screening for Nasal Staphylococcus aureus Carriage at the Day of Delivery, of
Discharge from the Ward, and Once Weekly Every Monday from February 20 Through April 1, 2012
TABLE 1A. Risk Factors for Colonization with Methicillin-Susceptible Staphylococcus aureus (Univariate and Multivariate Analyses)
Characteristics
Colonized with
MSSA N= 29
Not Colonized with
MSSA N= 58
Unadjusted Odds
Ratio (95% CI) P Value
Adjusted Odds Ratio
(95% CI)
P
Value
Female sex, No. (%) 10 (35) 30 (52) 0.5 (0.2–1.2) .13
Gestation age, wk, median (range) 34 (27–41) 36 (25–42) .002
Gestation age <33 weeks, No. (%) 12 (41) 7 (12) 5.1 (1.7–15.2) .005
Birth weight, g, median (range) 1,920 (570–3,940) 2,465 (840–4,130) .004
Birth weight <1,500 g, No. (%) 8 (28) 2 (4) 10.7 (2.1–54.4) .002 2.6 (0.4–16.8) .32
Length of stay, d, median (range) 14 (3–74) 6 (0–35) <.001
Length of stay >14 d 14 (48) 7 (12) 6.8 (2.3–19.9) <.001 2.8 (0.8–10.4) .12
Stay in incubator, No. (%) 19 (66) 25 (43) 2.5 (1.0–6.3) .07
Stay in incubator, d, median (range) 6 (0–40) 0 (0–10) .001
Stay in incubator >5 d, No. (%) 15 (52) 11 (19) 4.6 (1.7–12.2) .003
Stay in neonatal intensive care unit,
n (%)
18 (62) 12 (21) 6.3 (2.3–16.8) <.001
Ceasarian delivery, No. (%) 24 (83) 39 (67) 2.3 (0.7–7.1) .20
Parenteral nutrition, No. (%) 17 (59) 15 (26) 4.1 (1.6–10.4) .004
Surgical intervention, No. (%) 1 (3) 1 (2) 2.0 (0.1–33.8) 1.00
Any vascular catheter, No. (%) 23 (79) 20 (34) 7.3 (2.6–20.8) <.001 4.4 (1.4–13.6) .011
Central venous catheter, No. (%) 5 (17) 2 (3) 5.8 (1.1–32.2) .039
Umbilical arterial catheter, No. (%) 14 (48) 7 (12) 6.8 (2.3–19.9) <.001
Peripheral venous catheter, No. (%) 23 (79) 19 (33) 7.9 (2.7–22.5) <.001
NOTE. MSSA, methicillin-susceptible S. aureus; CI, conﬁdence interval
TABLE 1B. Risk Factors for Colonization with a PFGE-1-ST30 Staphylococcus aureus Strain (Univariate Analysis)
Characteristics Colonized with
PFGE 1-ST30 N= 11
Not Colonized or
Colonized with
Other Sequence
Type MSSA N= 76
Unadjusted Odds
Ratio (95% CI)
P
value
Female sex, No. (%) 4 (36) 36 (47) 0.6 (0.2–2.3) .54
Gestation age, wk, median (range) 31 (26–37) 36 (24–41) <.001
Gestation age <33 wk, No. (%) 6 (55) 13 (17) 5.8 (1.5–22.0) .012
Birth weight g, median (range) 1,550 (570–3,330) 2,375 (840–4,130) .004
Birth weight <1,500 g, No. (%) 5 (45) 5 (7) 11.8 (2.7–52.7) .002
Length of stay, d, median (range) 21 (4–74) 7 (0–52) .002
Length of stay >14 d 8 (73) 13 (17) 12.9 (3.0–55.4) <.001
Stay in neonatal intensive care unit,
No. (%)
8 (73) 22 (29) 6.5 (1.6–27.0) .007
Ceasarian delivery, No. (%) 11 (100) 52 (68) NA .03
Parenteral nutrition, No. (%) 7 (64) 25 (33) 3.6 (1.0–13.3) .09
Any vascular catheter, No. (%) 8 (73) 35 (46) 3.1 (0.8–12.7) .12
NOTE: PFGE, pulsed-ﬁeld gel electrophoresis; MSSA, methicillin-susceptible S. aureus; CI, conﬁdence interval.
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resistance34 and possible future treatment failure. Thus, we
focused our control efforts on standard infection control
measures including promoting hand hygiene through training
and ergonomic dispenser placement (Figure 1B).35 While
formally observed hand hygiene performance did not
signiﬁcantly improve with behavioral interventions, hand rub
consumption increased and HCW problem awareness
(measured anecdotally) did improve. Moving the NNW to a
new location was thought to act as behavior modiﬁer and to
eliminate any potential environmental source. While these
strategies failed to control clonal MSSA transmission between
babies, overall MSSA infection incidence decreased in 2013.
The main S. aureus strain was identiﬁed as PVL-negative
ST30 MSSA. ST30 is a very common genotype that can both
colonize and cause disease in inpatients and in the commu-
nity.36 Even though ST30 is circulating in Europe, it is not a
predominant genotype among MRSA or MSSA strains.37,38
Data on MSSA colonization rates and clonality in the neo-
natal population are rare. A pediatric study showed that by
100 hours of hospitalization, 43% of newborns of S. aureus–
colonized mothers were also colonized in contrast to 7% of the
newborns of S. aureus– negative mothers.25 HCWs and the
environment are likely sources for neonatal S. aureus coloni-
zation.2,29,30 Hence, it is difﬁcult to fully appraise the present
ﬁndings. In very young infants, colonization with S. aureus of
up to 40%, a level equal to our ﬁndings, seems to be physio-
logical in the community.39 A prevalence study in Swiss babies
<2 months of age, excluding neonates, examined the
prevalence within 2 days of hospital stay and found 42%MSSA
carriers.39 Acquisition is probably facilitated by the inexper-
ienced immune system. While S. aureus demonstrated high
genetic variability in the community,39 the clonality in our
investigation proves healthcare-associated transmission.
Even improving standard infection prevention measures to a
level that met or exceeded that of other NNWs did not seem
to prevent transmission. Consequently, clonal spread of MSSA
may occur inmanyNNWs around the world unnoticed, rendering
MSSA transmission an endemic situation rather than an outbreak.
In a recent account of S. aureus epidemiology among neonates,
39% (54 of 139) of included infants were affected by S. aureus, the
large majority of strains being methicillin susceptible.40 In this
study, S. aureus infection incidence was 12.2% (compared with
our incidence rates of 4.1% in 2012 and 2.0% in 2013). Of 6 cases
in a MSSA infection cluster, 5 showed the same PFGE type, but
typing of colonizing strains was not performed. A potential point
source concerned white protection gowns, while hand hygiene
compliance was 60% and 76% in two NNW sectors.
From these study results, an important question arises
regarding whether clonality leads to an increased burden of
MSSA infections directly through the virulence of pre-
dominant strains or indirectly via increased colonization rates.
Without prolonged prospective surveillance of colonization
and infection incidence, this question cannot be answered with
certainty. However, in our investigation, clonal strains were
less frequent in MSSA-infected neonates than in MSSA-
colonized neonates. PFGE-1-ST-30 was particularly successful
in spreading but less in generating infections.
conclusion
With this report, we add insights into the hitherto scarcely
known epidemiology of methicillin-susceptible S. aureus in
a neonatal inpatient population. We found sustained
healthcare-associated clonal MSSA transmission resulting in
colonization more often than infection. Based on strain typing,
observations, environmental specimens, and analysis of risk
factors, direct and indirect spread via HCW hands constituted
the most likely explanation. Clonal spread did not cease with
multimodal control measures, but MSSA infection incidence
decreased. Whether eradication of the clonal MSSA strains
would lead to reduced infection rates remains an open question.
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